Human papillomavirus infection leads to myocardial infarction and stroke in women
Women with signs of human papillomavirus infection are statistically significantly more likely to develop myocardial infarction or stroke.

Women with signs of human papillomavirus (HPV) infection are statistically significantly more likely to develop myocardial infarction or stroke, a similar study was published in the November issue of the journal Journal of the American College of Cardiology for 2011 [1].
The association of HPV with cardiovascular events, particularly pronounced in women infected with HPV genotypes associated with cancer, has been shown to be independent of risk factors for cardiovascular events and their treatment, concomitant diseases and protein C level. -reactive in 2450 women who participated in the National Survey on Health and Nutrition Review (NHANES), 2003-2006.
The findings of this study suggest that traditional risk factors cannot fully explain the relationship between HPV and death from cardiovascular disease, and that the presence of HPV infection, particularly cancer-associated genotypes, is strongly and is independently correlated with mortality from cardiovascular events.
In addition to the fact that HPV is the causative agent of cervical cancer, this pathogen may play a role in the development of cardiovascular disease. Determining the presence of HPV can be useful in identifying and determining the category of patients at risk of death from cardiovascular disease who may need additional efforts to avoid the development of cardiovascular events.
In addition, the results of this study may provide the basis for a theoretical rationale for the additional benefit of preventing cardiovascular morbidity in women vaccinated against HPV.
Currently, a large number of pathogens of chronic infections are considered to be important factors affecting the development of atherosclerotic changes in the cardiovascular system, which is confirmed in numerous studies [2]. However, despite more than 20 years of research in this area, the hypothesis that any specific causative agent of chronic infectious diseases contributes significantly to the onset and progression of atherosclerosis remains only a hypothesis which does not has been neither proven nor denied.
The current study was simultaneous and therefore could not demonstrate whether or not HPV causes cardiovascular disease, but it does indicate a causal relationship.
Additional large-scale studies should be conducted in women of all ages to confirm or refute this claim. The first studies in this area were the Muhlestein studies, which studied active antibiotic therapy against Chlamydia pneumoniae as a possible alternative treatment for cardiovascular disease.
In this analysis, vaginal smears from women (mean age 38 years) were sent to determine the DNA of HPV; 46.6% of patients had positive results. In a cohort of 60 women (approximately 2.5%) reported that they had already been diagnosed with myocardial infarction or stroke; HPV was detected in 39 patients and the survey results were negative in 21 patients.
Thus, this study added another important infectious "candidate" to the list of potential pathogens associated with the development, progression or destabilization of atherosclerotic lesions of the cardiovascular system.